Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice

British Journal of Dermatology

Volumn 159, Issue 2, 2008, Pages 306-313

  Atarashi, K ^a,b   Kabashima, K ^a   Akiyama, K ^b   Tokura, Y ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b HISAMITSU PHARMACEUTICAL CO INC   (Japan)

Author keywords

Contact hypersensitivity; Ketoprofen; Langerhans cell; Maturation; Migration; Prostaglandin E2

Indexed keywords

CD86 ANTIGEN; HAPTEN; INDOMETACIN; KETOPROFEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PICRYL CHLORIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CULTURE; CELL STRUCTURE; CONTACT ALLERGY; CONTROLLED STUDY; EAR; EPIDERMIS; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LANGERHANS CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGEN PRESENTATION; ANTIGENS, CD86; CELLS, CULTURED; DERMATITIS, CONTACT; DINOPROSTONE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; KETOPROFEN; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; PICRYL CHLORIDE; SKIN;

EID: 47549101407     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08683.x     Document Type: Article

References (37)

1. Hauser C, Elbe A, Stingl G. The Langerhans cell. In : Physiology, Biochemistry, and Molecular Biology of the Skin (Goldsmith LA, ed. 2nd edn. New York : Oxford Unversity Press, 1991 1144 63.
2. Aiba S, Katz SI. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 1990 145 : 2791 6.
3. Rattis FM, Peguet-Navarro J, Staquet MJ et al. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol 1996 26 : 449 53.
4. Chang CH, Furue M, Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol 1995 25 : 394 8.
5. Peguet-Navarro J, Dalbeiz-Gauthier C, Rattis FM et al. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 1995 155 : 4241 7.
6. Salgado CG, Nakamura K, Sugaya M et al. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells. J Invest Dermatol 1999 113 : 1021 7.
7. Witmer-Pack MD, Olivier W, Valinsky J et al. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 1987 166 : 1484 98.
8. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988 167 : 700 5.
9. Koch F, Heufler C, Kampgen E et al. Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med 1990 171 : 159 71.
10. Nakae S, Naruse-Nakajima C, Sudo K et al. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int Immunol 2001 13 : 1471 8.
11. Jakob T, Udey MC. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 1998 160 : 4067 73.
12. Hammarstrom S, Lindgren JA, Marcelo C et al. Arachidonic acid transformations in normal and psoriatic skin. J Invest Dermatol 1979 73 : 180 3.
13. Ujihara M, Horiguchi Y, Ikai K, Urade Y. Characterization and distribution of prostaglandin D synthetase in rat skin. J Invest Dermatol 1988 90 : 448 51.
14. Kabashima K, Sakata D, Nagamachi M et al. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 2003 9 : 744 9.
15. Angeli V, Faveeuw C, Roye O et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 2001 193 : 1135 47.
16. Tokura Y, Yagi J, O'Malley M et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994 102 : 31 8.
17. Cumberbatch M, Dearman RJ, Kimber I. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta. Immunology 2002 105 : 466 77.
18. Girolomoni G, Simon JC, Bergstresser PR, Cruz PD Jr. Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short-term culture. J Immunol 1990 145 : 2820 6.
19. Lee MG, Borkowski TA, Udey MC. Regulation of expression of B7 by murine Langerhans cells: a direct relationship between B7 mRNA levels and the level of surface expression of B7 by Langerhans cells. J Invest Dermatol 1993 101 : 883 6.
20. Amin AR, Vyas P, Attur M et al. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 1995 92 : 7926 30.
21. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998 104 : 413 21.
22. Yano T, Nakagawa A, Tsuji M, Noda K. Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sci 1986 39 : 1043 50.
23. Cordero JA, Alarcon L, Escribano E et al. A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J Pharm Sci 1997 86 : 503 8.
24. Nakazawa T, Shimo T, Chikamatsu N et al. Study on the mechanism of photosensitive dermatitis caused by ketoprofen in the guinea pig. Arch Toxicol 2006 80 : 442 8.
25. Matasic R, Dietz AB, Vuk-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 2000 101 : 53 60.
26. Hackstein H, Morelli AE, Larregina AT et al. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 2001 166 : 7053 62.
27. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994 265 : 956 9.
28. Frantz B, O'Neill EA. The effect of sodium salicylate and aspirin on NF-kappa B. Science 1995 270 : 2017 19.
29. Wieser F, Vigne JL, Ryan I et al. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 2005 90 : 6441 7.
30. Yip-Schneider MT, Nakshatri H, Sweeney CJ et al. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther 2005 4 : 587 94.
31. d. Mol Cell Biol 1989 9 : 844 6.
32. Li J, Liu Z, Jiang S et al. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J Immunol 1999 163 : 6386 92.
33. Cusano F, Rafenelli A, Bacchilega R, Errico G. Photo-contact dermatitis from ketoprofen. Contact Dermatitis 1987 17 : 108 9.
34. Nabeya RT, Kojima T, Fujita M. Photocontact dermatitis from ketoprofen with an unusual clinical feature. Contact Dermatitis 1995 32 : 52 3.
35. Le Coz CJ, Bottlaender A, Scrivener JN et al. Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis 1998 38 : 245 52.
36. Imai S, Atarashi K, Ikesue K et al. Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells. J Dermatol Sci 2006 41 : 127 36.
37. Atarashi K, Kabashima K, Akiyama K, Tokura Y. Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen. J Dermatol Sci 2007 47 : 151 9.